Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized , Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate Efficacy and Safety of Oral BT-11 in Ulcerative Colitis

NCT03861143 is registered in ClinicalTrials.gov with NImmune Biopharma as lead sponsor.

NCT NCT03861143
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03861143 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized , Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate Efficacy and Safety of Oral BT-11 in Ulcerative Colitis
Lead sponsor
NImmune Biopharma
Phase
Phase 2
Overall status
Completed
Start date
August 14, 2019
Completion date
June 17, 2021
Enrollment
198 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis